IP litigation spending surges; Samsung transfers patents to NPE; NASA portfolio profile; Chinese companies use IP as collateral to borrow $8.5 billion; Pharma licensing deals drop; and much more  IAM

Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week.